FNCH
Finch Therapeutics Group Inc
Price:
1.8
USD
Volume:
629,479
United States | Biotechnology
No data available for this ticker
FNCH Probability of Bankruptcy
The Probability of Bankruptcy of Finch Therapeutics Group Inc (FNCH) is 0% . This number represents the probability that FNCH will face financial distress in the next 24 months given its current fundamentals and market conditions.
Multiple factors are taken into account when calculating FNCH's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.
FNCH - Historical Solvency Measures
to of
Page of
FNCH - ESG ratings
ESG ratings are directly linked to the cost of capital and FNCH's ability to raise funding, both of which can significantly affect the probability of Finch Therapeutics Group Inc going bankrupt.
ESG Score
51.2
Environment Score
57.08
Social Score
41.82
Governance Score
54.69
| Returns | |
| Historical Returns (5 day) | 5.88% |
| Historical Returns (MTD) | 8% |
| Historical Returns (YTD) | 19.47% |
| Historical Returns (13 week) | 17.39% |
| Historical Returns (26 week) | 17.39% |
| Historical Returns (52 week) | 505.38% |
| Efficiency | |
| Asset Turnover | 0 |
| Receiveable Turnover | 2.2 |
| Gross Margin | 100% |
| Operating Margin | - |
| Pretax Margin | - |
| Net Margin | - |
| Return on Asset (ROA) | -26.92 |
| Return on Equity (ROE) | -69.17 |
| Return on Investments (ROI) | -69.17 |
| Price Metrics | |
| Market Cap (M) | 21.8 |
| Enterprise Value (M) | 5.8 |
| 52 Week High | 15.85 |
| 52 Week Low | 0.8 |
| Beta | 1.36 |
| Average Volume (10 day) | 0 |
| Average Volume (3 month) | 0 |
| Price / Earnings (P/E) | - |
| Price / Sales (P/S) | 35 |
| Earnings | |
| EPS | -8.83 |
| Revenue CAGR (5 year) | - |
| Risk | |
| Current Ratio | 3.87 |
| Quick Ratio | 3.59 |